Literature DB >> 2104525

National High Blood Pressure Education Program Working Group Report on High Blood Pressure in Pregnancy.

.   

Abstract

This consensus report focuses the presentation, pathophysiology, and management of the hypertensive disorders of pregnancy expanding on recommendations first presented in 1988 by the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Practicing physicians should determine whether a patient's hypertension during pregnancy falls into the classification of (1) chronic hypertension, (2) preeclampsia, (3) preeclampsia superimposed on chronic hypertension, or (4) transient hypertension. The distinction, for management considerations, is made between hypertension that is present before pregnancy (chronic and preexisting) and that occurring as part of the pregnancy-specific condition preeclampsia. When maternal blood pressure reaches diastolic levels of 100 mm Hg or greater, treatment should be instituted to avoid hypertensive vascular damage. The report includes a discussion of antihypertensive therapy specific to the chronic or acute hypertension occurring concomitantly with pregnancy. The roles of calcium supplementation and low-dose aspirin to prevent preeclampsia and chronic and transient hypertension are under investigation.

Entities:  

Mesh:

Year:  1990        PMID: 2104525     DOI: 10.1016/0002-9378(90)90653-o

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  62 in total

Review 1.  Fortnightly review: management of hypertension in pregnancy.

Authors:  L A Magee; M P Ornstein; P von Dadelszen
Journal:  BMJ       Date:  1999-05-15

Review 2.  Pathophysiology and maternal biologic markers of preeclampsia.

Authors:  Jacques Massé; Yves Giguère; Abdelaziz Kharfi; Joël Girouard; Jean-Claude Forest
Journal:  Endocrine       Date:  2002-10       Impact factor: 3.633

3.  L-arginine supplementation abolishes the blood pressure and endothelin response to chronic increases in plasma sFlt-1 in pregnant rats.

Authors:  Sydney R Murphy; Babbette LaMarca; Kathy Cockrell; Marietta Arany; Joey P Granger
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-11-09       Impact factor: 3.619

4.  Atypical case of acute Fatty liver of pregnancy.

Authors:  Nihal Al Riyami; Abdullah Al-Harthy; Fehmida Zia
Journal:  Sultan Qaboos Univ Med J       Date:  2011-10-25

Review 5.  Animal models of preeclampsia.

Authors:  Eduardo Podjarny; Gyorgy Losonczy; Chris Baylis
Journal:  Semin Nephrol       Date:  2004-11       Impact factor: 5.299

6.  C-reactive protein and tumor necrosis factor-alpha in gestational hyperglycemia.

Authors:  S Bo; A Signorile; G Menato; R Gambino; C Bardelli; M L Gallo; M Cassader; M Massobrio; G F Pagano
Journal:  J Endocrinol Invest       Date:  2005-10       Impact factor: 4.256

Review 7.  Liver diseases in pregnancy: diseases unique to pregnancy.

Authors:  Khulood T Ahmed; Ashraf A Almashhrawi; Rubayat N Rahman; Ghassan M Hammoud; Jamal A Ibdah
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

8.  Thrombophilia and damage of kidney during pregnancy.

Authors:  Larciprete Giovanni; Liumbruno Giancarlo Maria; Rongioletti Mauro; Montagnoli Carlotta; Rossi Federica; Papa Fabrizio; Jarvis Sheba; Di Pierro Giuseppe; Bompiani Alessandro; Cirese Elio; Valensise Herbert
Journal:  J Prenat Med       Date:  2011-10

Review 9.  Magnesium sulfate for the treatment of eclampsia: a brief review.

Authors:  Anna G Euser; Marilyn J Cipolla
Journal:  Stroke       Date:  2009-02-10       Impact factor: 7.914

10.  Pre-eclampsia, soluble fms-like tyrosine kinase 1, and the risk of reduced thyroid function: nested case-control and population based study.

Authors:  Richard J Levine; Lars J Vatten; Gary L Horowitz; Cong Qian; Pal R Romundstad; Kai F Yu; Anthony N Hollenberg; Alf I Hellevik; Bjorn O Asvold; S Ananth Karumanchi
Journal:  BMJ       Date:  2009-11-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.